Lobeglitazone is an antidiabetic medication from the thiazolidinedione class of drugs. It mainly functions as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated Receptors (PPAR) gamma within fat cells. It is grouped under the following drug class(es): Thiazolidinediones. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Duvie and Lobetron. Its PubChem CID is 9826451.
Lobeglitazone
| CAS No | 607723-33-1 |
|---|---|
| Molecular Formula | C24H24N4O5S |
| Molecular Weight | 480.50 g/mol |
| Synonyms | 5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lobeglitazone is an antidiabetic medication from the thiazolidinedione class of drugs. It mainly functions as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated Receptors (PPAR) gamma within fat cells.
The listed CAS number is 607723-33-1.
The listed molecular formula is C24H24N4O5S.
The listed molecular weight is 480.50 g/mol.
5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione.
The source lists Duvie and Lobetron.